The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr2
start 176150303
end 176150412
ID MI0000267
miRNA_name hsa-miR-10b
methods qRT-PCR,Microarray,etc.
regulated down
Function Description In summary, we have presented, for the first time, a luminal mammary cancer progression-associated miRNA profile and have shown that CR prevents the dysregulation of one of thesemiRNA, miR-200a. Further, we have shown that CR greatly reduces tumor initiation andgrowth, a protective effect that can be explained, at least in part, through CR¡¯s normalization ofmiR-200a expression and resultant inhibition of cellular proliferation. These findings deepenour understanding of the dysregulation of miRNA throughout cancer progression and suggestthat miR-200a may be a novel intervention target for mimicking the suppressive effects of CRon mammary tumor development and growth.
PMID 27433802
year 2016
Title Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer
drug X
circulating X
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China